Research News and Research

RSS

Researchers identify biomarker that can predict diabetes risk

Researchers at the Vanderbilt Heart and Vascular Institute and Massachusetts General Hospital have identified a biomarker that can predict diabetes risk up to 10 years before onset of the disease.

17 Sep 2013

Researchers find that people affected by cold sores have mutation in gene

Why some people are troubled by cold sores while others are not has finally been explained by scientists. Cold sores affect around one in five people but, until now, no one has been sure why some are more prone to the virus that causes them.

17 Sep 2013

Arginine therapy may be safe treatment for patients with sickle cell disease

Arginine therapy may be a safe and inexpensive treatment for acute pain episodes in patients with sickle cell disease, according to results of a recent clinical study. The study was the first randomized placebo-controlled study to demonstrate benefits of arginine therapy in children with sickle cell disease hospitalized for severe pain.

17 Sep 2013

Attention drawn to COPD in never smokers

Research from Denmark shows that, while never smokers with chronic obstructive pulmonary disease typically experience milder disease than their smoking counterparts, they still have substantial morbidity due to COPD- and pneumonia-related hospital admissions.

16 Sep 2013

Insomnia poses hypertension risk

Insomnia may be associated with an increased risk for hypertension, research from China suggests.

16 Sep 2013

Financial incentives only partial solution for hypertension control

Providing financial incentives to general practitioners goes some way toward improving hypertension control in their patients, shows research published in JAMA.

16 Sep 2013

Phone support boost to COPD patients

Researchers from Australia have found that even brief phone contact from medical professionals can provide benefits to patients with chronic obstructive pulmonary disease.

16 Sep 2013

Studying Tumor Mutations Via A Network Approach

...

16 Sep 2013

Sigma-Tau Pharmasource, Aradigm Ink Manufacturing Deal For Respiratory Disease Treatment

...

16 Sep 2013

Bruker Launches Second Phase Of SISCAPA-MALDI Collaboration

After focusing on confirming the utility and quantitative precision of the SISCAPA-MALDI workflow in the collaboration's first phase, Bruker said it plans to establish fully automated SISCAPA-MALDI capabilities in its demonstration facilities.

16 Sep 2013

Smoking-cessation in HIV-positive individuals: an interview with Dr Ellen R. Gritz, University of Texas MD Anderson Cancer Center

In the general population, current smoking prevalence is 18%. Persons living with HIV/AIDS smoke at a rate 2 to 3 times higher, up to almost 70% in some studies.

16 Sep 2013

Affimed Therapeutics, LLS partner to co-fund AFM13 phase 2 trial for treatment of Hodgkin Lymphoma

Affimed Therapeutics AG and The Leukemia & Lymphoma Society today announced a partnership to co-fund a phase 2 trial with the Recruit-TandAb AFM13, a novel tetravalent bispecific antibody directed against human CD30 and CD16A in Hodgkin Lymphoma patients for whom currently available treatments have failed.

16 Sep 2013

ISA Pharmaceuticals announces initiation of ISA101 Phase I/II trial in HIV-positive men with AIN

ISA Pharmaceuticals B.V., a clinical-stage biopharmaceutical company focusing on rationally designed, fully synthetic therapeutic vaccines against cancer and persistent viral infections, today announced the initiation of a Phase I/II clinical study of its lead candidate ISA101 in HIV-positive men suffering from anal intraepithelial neoplasia.

16 Sep 2013

Bangkok Hospital Group selects Elsevier's ClinicalKey to support clinical decision-making

Elsevier's flagship 'clinical insight engine' provides fast, comprehensive and trusted medical content and answers to more than 500 clinicians.

16 Sep 2013

First Edition: September 16, 2013

Today's headlines include reports about new polling indicating that the health law still faces an uphill climb.

16 Sep 2013

Speed Queen partners with BCRF to support search for breast cancer cure

For over 100 years, Speed Queen has been committed to manufacturing best-in-class laundry equipment to make families' lives easier. Today, the brand is reinforcing its commitment to families by partnering with The Breast Cancer Research Foundation (BCRF) to support the search for a cure for breast cancer by donating a portion from the purchase of a limited-edition washer and dryer pair.

16 Sep 2013

Kinder chemistry promises cleaner and safer pharmaceuticals with fewer side-effects

A new and kinder chemistry promises cleaner and subsequently safer pharmaceuticals with fewer side-effects. The ground-breaking method, developed by a chemistry research group at the University of Copenhagen, is now published in the internationally renowned journal, Chemical Communications, as "Site-selective three component reaction for dual functionalization of peptides".

16 Sep 2013

Scientists develop antibiotic whose activity can be controlled using light

Scientists at the University of Groningen have developed an antibiotic whose activity can be controlled using light. It is possible to 'switch on' the substance immediately before use, after which it will slowly lose its activity.

16 Sep 2013

New neuroimaging and bioinformatics tools for predicting psychotic disorders

A new EU project, METSY, develops and applies neuroimaging and bioinformatics tools to study how lipid metabolism is connected to psychotic disorders and metabolic co-morbidities such as metabolic syndrome and diabetes.

16 Sep 2013

Flights are major risk factors for bouts of inflammation in IBD patients

Patients with a chronic intestinal inflammation often experience bouts of inflammation after a journey. The main cause of this is not the stress of travelling, but the lack of oxygen experienced in an aircraft or during high altitude stays in the mountains.

16 Sep 2013

Research News and Research

Researchers identify biomarker that can predict diabetes risk

Researchers find that people affected by cold sores have mutation in gene

Arginine therapy may be safe treatment for patients with sickle cell disease

Attention drawn to COPD in never smokers

Insomnia poses hypertension risk

Financial incentives only partial solution for hypertension control

Phone support boost to COPD patients

Studying Tumor Mutations Via A Network Approach

Sigma-Tau Pharmasource, Aradigm Ink Manufacturing Deal For Respiratory Disease Treatment

Bruker Launches Second Phase Of SISCAPA-MALDI Collaboration

Smoking-cessation in HIV-positive individuals: an interview with Dr Ellen R. Gritz, University of Texas MD Anderson Cancer Center

Affimed Therapeutics, LLS partner to co-fund AFM13 phase 2 trial for treatment of Hodgkin Lymphoma

ISA Pharmaceuticals announces initiation of ISA101 Phase I/II trial in HIV-positive men with AIN

Bangkok Hospital Group selects Elsevier's ClinicalKey to support clinical decision-making

First Edition: September 16, 2013

Speed Queen partners with BCRF to support search for breast cancer cure

Kinder chemistry promises cleaner and safer pharmaceuticals with fewer side-effects

Scientists develop antibiotic whose activity can be controlled using light

New neuroimaging and bioinformatics tools for predicting psychotic disorders

Flights are major risk factors for bouts of inflammation in IBD patients

New Approach Methodologies, the 3Rs and Multimodal Imaging in Preclinical Research - eBook eBook

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (2nd Edition)

BFEB: Advances in microplate-based assays and analysis

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery